Quoted from
http://seekingalpha.com/article/187575-chemgenex-a-snow-fueled-setback-at-the-fda?source=from_friend
"Negative comments from FDA reviewers coupled with snow in Washington have changed the game for the first-in-class chronic myeloid leukaemia (CML) treatment, and with it, ChemGenex Pharmaceuticals (CXSPY.PK) market fortunes."
Does anybody know what the exact wordings were of these negative comments?
Thanks from David
Add to My Watchlist
What is My Watchlist?